7SHU
IgE-Fc in complex with omalizumab variant C02
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | APS BEAMLINE 21-ID-F |
Synchrotron site | APS |
Beamline | 21-ID-F |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2018-10-10 |
Detector | MARMOSAIC 225 mm CCD |
Wavelength(s) | 0.978720 |
Spacegroup name | C 2 2 21 |
Unit cell lengths | 90.070, 176.120, 142.760 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 49.190 - 2.750 |
R-factor | 0.2226 |
Rwork | 0.220 |
R-free | 0.27460 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5hys |
RMSD bond length | 0.003 |
RMSD bond angle | 0.548 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHENIX |
Refinement software | PHENIX (1.10_2155) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 49.190 | 2.848 |
High resolution limit [Å] | 2.750 | 2.750 |
Number of reflections | 29871 | 2928 |
<I/σ(I)> | 19.21 | 1.83 |
Completeness [%] | 99.8 | |
Redundancy | 8.3 | |
CC(1/2) | 0.999 | 0.676 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 291 | 0.2M Lithium sulfate, 0.1 M Phosphate citrate pH 4.2, 20% (w/v) PEG 1000 |